MERRIMACK PHARMACEUTICALS INC 3 SEC Filings

Filed On	Filing
17 Jun 2022	Form 3: Radeljevic Ana, Director
27 Sep 2019	Form 3: Levy Noah G., Director and 5 others Holds 677,546 shares of Common Stock
27 Sep 2019	Form 3: Andersen Eric, Director and 3 others Holds 666,327 shares of Common Stock
25 Jul 2019	Form 3: 22NW GP, Inc., 10% owner Holds 1,241,896 shares of Common Stock
20 Mar 2019	Form 3: Lin Kenneth, 10% owner Holds 5,000 shares of Common Stock
20 Mar 2019	Form 3: Aryeh Jason, 10% owner Holds 0 shares of Common Stock
20 Mar 2019	Form 3: 22NW, Lp, 10% owner and 3 others Holds 1,092,263 shares of Common Stock
20 Mar 2019	Form 3: Jfl Capital Management, Llc, 10% owner and 4 others Holds 485,026 shares of Common Stock
01 Dec 2017	Form 3: Demetri George, Director No securities owned
28 Aug 2017	Form 3: Franchi Jean M., Chief Financial Officer No securities owned
25 Jul 2017	Form 3: Needham Thomas E. Jr., Chief Business Officer No securities owned
20 Jun 2017	Form 3: Green John L., Principal Accounting Officer
15 Jun 2017	Form 3: Santillana Sergio L., Chief Medical Officer No securities owned
10 Apr 2017	Form 3: Drummond Daryl C, Head of Research Holds 92,420 shares of Common Stock
10 Apr 2017	Form 3: Munsie Jeffrey A, General Counsel
09 Feb 2017	Form 3: Peters Richard, Director No securities owned
13 Aug 2015	Form 3: Al-Wakeel Yasir B., CFO and Head of Corp Dev No securities owned
16 Jun 2015	Form 3: Dineen John M., Director No securities owned
06 Feb 2015	Form 3: Schoeberl Birgit M., Head of Discovery Holds 3,600 shares of Common Stock
08 Jan 2015	Form 3: Ray Russell T, Director Holds 10,000 shares of Common Stock

Comments